Breaking News, Collaborations & Alliances

Shimadzu, bioMerieux Enter Mass Spec Pact

Shimadzu and bioMerieux have entered into a partnership to commercialize a mass spectrometry system for bacterial identification in microbiology labs.

Author Image

By: Tim Wright

Editor-in-Chief, Contract Pharma

Shimadzu and bioMerieux have entered into a partnership to commercialize a mass spectrometry system for bacterial identification in microbiology labs. BioMerieux will work with Shimadzu and its subsidiary, Kratos Analytical, to adapt their MALDI-TOF mass spectrometry technology for optimized integration into the microbiology lab workflow. BioMerieux expects to launch the new solution in 2010, together with the microbial database acquired from AnagnosTec. The collaboration brings together Shim...

Continue reading this story and get 24/7 access to Contract Pharma for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters